Sarah Slater
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 5%
- Surgery top 10%
- Molecular Biology
- Gastroenterology top 5%
- Co-authors
- R.T.D. OliverGary MiddletonJonathan WadsleyIan ChauWasat MansoorAndrew WotherspoonDavid CunninghamDavid Ferry
- Topics
- Gastric Cancer Management and Outcomes (6 papers)Pancreatic and Hepatic Oncology Research (5 papers)Hepatocellular Carcinoma Treatment and Prognosis (5 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaThe Lancet Oncology
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Sarah Slater
37 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Pulmonary and Respiratory Medicine 650
- Oncology 527
- Surgery 320
- Molecular Biology 170
- Gastroenterology 166
Countries citing papers authored by Sarah Slater
This map shows the geographic impact of Sarah Slater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Slater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Slater more than expected).
Fields of papers citing papers by Sarah Slater
This network shows the impact of papers produced by Sarah Slater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Slater. The network helps show where Sarah Slater may publish in the future.
Co-authorship network of co-authors of Sarah Slater
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Slater. A scholar is included among the top collaborators of Sarah Slater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Slater. Sarah Slater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 58 | |
| 8 | 19 | |
| 9 | 22 | |
| 10 | 40 | |
| 11 | 19 | |
| 12 | Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trialbreakdown → | 547 |
| 13 | Notes from a Solutions Network Presentation - Making the Oral Presentation Work for VCE Students with Literacy and Motivational Difficulties | 1 |
| 14 | 108 | |
| 15 | 13 | |
| 16 | 13 | |
| 17 | 4 | |
| 18 | 74 | |
| 19 | 5 | |
| 20 | 13 |
About Sarah Slater
Sarah Slater is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 1.1k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Gastroenterology (166 citations), Pulmonary and Respiratory Medicine (650 citations) and Oncology (527 citations). Sarah Slater has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include R.T.D. Oliver, Gary Middleton, Jonathan Wadsley, Ian Chau, Wasat Mansoor, Andrew Wotherspoon, David Cunningham, David Ferry, Timothy Iveson and Alicia Okines. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.